The activity of MnSOD is decreased in the retina in diabetes, its expression is down regulated, and the therapy that inhibits the development of retinopathy in diabetes also inhibits diabetes-induced decrease in MnSOD activity [19, 31]. Here, SOD2 is linked to diabetes mellitus.